Construction of a multi-parametric ultrasonographic nomogram for precise assessment of papillary breast lesions
British Journal of Radiology · 2025
DOI: 10.1093/bjr/tqae242 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Radiology, 2025. Verfasst von Yunhua Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China. Hauptthemen laut MEDLINE: Nomograms, Breast Neoplasms, Ultrasonography, Mammary, Carcinoma, Papillary. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Objectives
To analyze the multi-parametric ultrasonographic (MpUS) features of atypical/malignant papillary lesions of the breast with clinical information, identify independent risk factors, and construct a nomogram to improve the diagnostic accuracy.
Methods
This retrospective study analyzed consecutively hospitalized patients diagnosed with pathologically confirmed papillary breast lesions from January 2017 to June 2023. Preoperative sonographic examinations, including gray-scale ultrasound (G-US), color Doppler flow imaging (CDFI), and contrast-enhanced ultrasound (CEUS), were conducted. Sonographic scans were retrospectively reviewed alongside clinicopathological data. Binary logistic regression identified independent risk factors for screening atypical/malignant papillary lesions. The receiver operating characteristic curve evaluated the predictive accuracy of these lesions, resulting in the development of a nomogram for assessing risk.
Results
The study involved 176 female patients with breast papillary lesions, identifying key predictors for atypical or malignant outcomes: age 57 or order, US diameter ≥13.95 mm, resistive index ≥0.70, enlarged enhancement on CEUS, and contrast agent retention, with respective odds ratios of 6.279, 8.078, 9.246, 9.401, and 5.047. The integrated use of G-US, CDFI, and CEUS in the MpUS approach offered higher diagnostic accuracy (area under the curve [AUC]: 0.966) than G-US or CDFI alone (0.869/0.918). CEUS particularly enhanced prediction for non-mass-like lesions, with a positive predictive value of 83.3%. A nomogram incorporating MpUS and patient age achieved an AUC of 0.956 for predicting atypical or malignant papillary lesions.
Conclusions
MpUS imaging is highly effective for predicting malignant breast papillary lesions, especially considering patient age. The nomogram offers an intuitive framework for assessing malignant risk in these lesions. Advances in knowledge Ultrasound excels in identifying papillary lesions, and integrating diverse data and multi-parametric imaging enhances malignant risk evaluation. This study establishes a predictive risk model using the nomogram method, demonstrating heightened diagnostic efficacy in breast papillary lesions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ultrasound, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.
- Department of Nursing, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.
Zitieren
APA
Li, Y., Li, H., Du, L., Shi, Q., Li, G., Jia, C., Jin, L., Liang, H., & Li, F. (2025). Construction of a multi-parametric ultrasonographic nomogram for precise assessment of papillary breast lesions. British Journal of Radiology. https://doi.org/10.1093/bjr/tqae242
Vancouver
Li Y, Li H, Du L, Shi Q, Li G, Jia C, et al. Construction of a multi-parametric ultrasonographic nomogram for precise assessment of papillary breast lesions. British Journal of Radiology. 2025. doi:10.1093/bjr/tqae242
BibTeX
@article{Li2025,
author = {Li, Yunhua and Li, Hui and Du, Lianfang and Shi, Qiusheng and Li, Gang and Jia, Chao and Jin, Lifang and Liang, Hongmei and Li, Fan},
title = {Construction of a multi-parametric ultrasonographic nomogram for precise assessment of papillary breast lesions},
journal = {British Journal of Radiology},
year = {2025},
doi = {10.1093/bjr/tqae242}
}
EUVIMED